| For Eastman Dental Hospital patient enquiries, please visit their website or call them directly on 020 3456 7899. |
|
The Institute is supported by the Eastman Foundation For Oral Research & Training. Help support our work |
Professor Brian Henderson
| Name: | Brian Henderson | Email: | brian.henderson@ucl.ac.uk |
| Title: | Professor | Tel: | +44 (0)20 3456 1190 |
| Qualifications: | PhD | Fax: | +44 (0)20 3456 1190 |
| Position: | Boissard Chair Cell Biology | Address: |
Division of Microbial Diseases UCL Eastman Dental Institute 256 Gray's Inn Road London WC1X 8LD UK |
Background
Professor Henderson graduated in 1972
with an honours degree in Biochemistry and after a one year postgraduate
course in bioengineering started his PhD in 1974 in the Division of
Cellular Biology of the Kennedy Institute of Rheumatology, London
studying the cell biology of synovial lining cells in rheumatoid
arthritis.
After gaining his PhD in 1977, Professor Henderson spent
a year in the Department of Medicine at McGill University, Montreal,
Canada working on thyroid disease. Returning to the University of London
he started working on experimental arthritis with Professor Leonard
Glynn and Dr Norman Staines at the Kennedy Institute. This was followed
by two years working at King's College London with Dr Staines studying
the role of anti-idiotypic antibodies in the control of collagen-induced
arthritis.
In 1983 Professor Henderson took up a lectureship in Chemical Pathology at King's College Hospital Medical School working with Professor Mervyn Smith. In 1984 he joined the Department of Pharmacology of the Wellcome Research Laboratories in Kent then run by Dr (now Professor) Salvador Moncada FRS. During the 5 years spent at the Wellcome Laboratories Professor Henderson managed two multidisciplinary teams developing: (i) cytokine inhibitors and (ii) inhibitors of matrix metalloproteinases. Professor Henderson became Head of the Anti-inflammatory Section in the Department of Pharmacology. In 1989 Professor Henderson joined the Biotechnology Company, Celltech Therapeutics, as Head of Immunobiology - in which post he was responsible for the pharmacological studies of anti-cytokine antibodies and for testing metalloproteinase inhibitors.
In 1990 Professor
Henderson joined the Oral and Maxillofacial Surgery Unit as Senior
Lecturer and set up the Cellular Microbiology Research Group. In 1993
the Boissard Chair of Biochemistry was established with Professor
Henderson as the incumbent. In 1999 the title of the chair was changed
to Cell Biology. Much of the work done by Professor Henderson is in
collaboration with Professor Wilson's Microbiology group. This
collaborative grouping is devoted to the study of the interactions of
bacteria with eukaryotic cells.
Professor Henderson is on the Advisory Board of
Inflammation Research and the Editorial Board of Cell Biochemistry and
Function and the Journal of Periodontal Research. He has served on the
Scientific Sub-committee of the Arthritis Research Campaign and the
Society for General Microbiology, Microbial Infection Committee.
Current Research
Professor Henderson's research centres around the interactions of bacteria with myeloid and lymphoid cells and this work is done in collaboration with Professor Wilson's group. The research can be divided into three project areas which all relate to cytokine biology: The average human body contains ten times as many bacteria as it does human cells. This enormous number of bacteria,which constitutes the normal microflora, does not cause inflammation. As these bacteria contain many pro-inflammatory components the failure to induce inflammation is paradoxical. Professors Henderson and Wilson have developed the hypothesis that the failure of the normal microflora to cause inflammation is due to their production of anti-inflammatory cytokine-like molecules which have been termed microkines. The Cellular Microbiology Group is attempting to identify, isolate and characterise such proteins by using protein biochemistry and gene cloning and expression. It is proposed that such proteins represent the anti-inflammatory therapeutics of the future. Professors Henderson and Wilson, in collaboration with Dr John Ward and Dr Don Cowan of the Molecular Microbiology Group in the Department of Biochemistry and Molecular Biology, UCL, have set up a company called Penteos Therapeutics to advance these ideas commercially.
Professor Henderson has been
instrumental in establishing that the intracellular protein-folding
proteins known as chaperonins are potent inducers of bone resorption and
of myeloid cell cytokine synthesis. It is proposed that these
chaperonins play a key role in bacterial infections of bone and in
bacterial infections generally in which they may represent a major
stimulus for cytokine induction. Human chaperonins may also be involved
in idiopathic conditions such as rheumatoid arthritis and osteoporosis
and there is good evidence for their involvement in atherogenesis.
The interaction of bacteria with bone cells has been
actively studied over the past few years and it has been established
that bacteria contain a number of molecules, in addition to chaperonins,
which can modulate bone cell behaviour to either inhibit bone matrix
synthesis or stimulate bone matrix breakdown. Bacterial protein with
such actions are being cloned using phage display and direct activity
screening strategies.
Publications
Professor Henderson is the author of 180 scientific papers and reviews and has published nine books, one monograph and two PharmaConnect Reports on Arthritis Therapy.
Books
Wilson M, McNab R, Henderson B. Bacterial Disease Mechanisms: An Introduction to Cellular Microbiology. Cambridge University Press 2002.
Higgs, G.A., Henderson, B. Novel Cytokine Inhibitors. Birkhauser: Basel 2000.
Henderson B, McNab R, Wilson M, Lax A. Cellular Microbiology: Prokaryotic-Eukaryotic Interactions in Health and Disease. John Wiley: Chichester 1999.
Henderson B, Poole S, Wilson M. Bacteria/cytokine Interactions in Health and Disease . Portland Press:London 1998.
Arnett TR, Henderson B. Methods in Bone Biology . Chapman & Hall: London 1998
Henderson B, Bodmer MW. Therapeutic Modulation of Cytokines . CRC Press: Boca Raton 1996.
Henderson B, Edwards JCW, Pettipher ER. Mechanisms and Models in Rheumatoid Arthritis. Academic Press: London 1995.
Recent papers
Page last modified on 12 oct 11 15:23
